Legal status · United States
Is Cartalax legal in the United States?
Written by Aaron CuhaReviewed Sep 2026
Direct answer
No. Cartalax is not an approved medicine in the United States; its classification is "Not approved; research use only". Nothing containing it is authorized for any use in people. Vials labeled "for research use only" are not exempt: that label does not make human use lawful. On the evidence, no human study is cited on its profile.
Cartalax in the United States at a glance
| Classification | Not approved; research use only |
|---|---|
| Note | No FDA evaluation. Retail Cytogen-style capsules are sold as supplements; injectable material is sold as a research chemical. |
| FDA approval status | Not approved for any indication in the United States and not evaluated by the FDA. Sold as a supplement or a research chemical depending on the vendor. |
| Human studies cited | 0 of 5 citations on the profile |
| Reviewed | Sep 2026 |
Classification and note come from the Cartalax profile, checked against U.S. Food and Drug Administration (FDA) listings at the reviewed date.
What this means
- 01
No product containing Cartalax is approved by FDA for any use in the United States, so nothing on the market is authorized for people.
- 02
"Research use only" is a vendor label, not a legal category that permits human use. It does not exempt a product from medicines law.
- 03
Importing, supplying or promoting it for human use can fall under medicines legislation in the United States. This page is general information, not legal advice.
What Cartalax is
A three amino acid peptide studied almost entirely in cell culture by the group that developed it. The only human claim is a sentence in a 2023 review saying it was given orally to older osteoarthritis patients; no primary report of that human use has been located.
Cartalax is Ala-Glu-Asp, written AED, one of a family of ultrashort peptides designed at the St. Petersburg Institute of Bioregulation and Gerontology and assigned to cartilage.
Mechanism: Proposed as epigenetic regulation by an ultrashort peptide that enters the cell and interacts with DNA and histones to shift transcription. In chondrocyte work AED is reported to normalise a senescence pattern characterised by raised p16, p21, p53, TNF-alpha and IL-1-alpha and lowered Sirt1.
Regulatory history: Not approved for any indication in the United States and not evaluated by the FDA. Sold as a supplement or a research chemical depending on the vendor.
How FDA treats this kind of product
Approves prescription drugs by indication and polices unapproved products, including peptides sold online. Compounding pharmacies may prepare some compounds under a prescription when the FDA places them on a permitted bulk-substances category.
The classification above is the The Longevity Archive reading of U.S. Food and Drug Administration listings for Cartalax at the reviewed date, not a legal opinion. Rules change, and importing, prescribing and possessing a compound can each be treated differently. Check the regulator directly before acting on anything here.
Cartalax in other countries
Frequently asked questions
Is Cartalax legal in the United States?
No. Cartalax is not an approved medicine in the United States; its classification is "Not approved; research use only". Nothing containing it is authorized for any use in people. Vials labeled "for research use only" are not exempt: that label does not make human use lawful. On the evidence, no human study is cited on its profile. Note: No FDA evaluation. Retail Cytogen-style capsules are sold as supplements; injectable material is sold as a research chemical.
Can I buy Cartalax in the United States?
No approved product exists to buy. In the United States Cartalax is classified as "Not approved; research use only", so there is no licensed pharmacy product. Vendors selling it "for research use only" are not selling it for human use, and that label does not change its legal status. This site does not list or recommend vendors. Note: No FDA evaluation. Retail Cytogen-style capsules are sold as supplements; injectable material is sold as a research chemical.
Is Cartalax FDA approved?
No. FDA status: Not approved for any indication in the United States and not evaluated by the FDA. Sold as a supplement or a research chemical depending on the vendor.. Current US classification: "Not approved; research use only". On the evidence, no human study is cited on its profile.
Related compounds in the United States
Full research profile
Mechanism, cited studies, FDA status and the full legal summary for Cartalax live on its compound profile.
Cartalax profileThis page is general information about the regulatory status of Cartalax in the United States, current as of Sep 2026. It is not legal advice, and classifications change; check U.S. Food and Drug Administration directly or consult a lawyer for a specific situation. Educational use only. This database summarizes published research. It is not medical advice and contains no dosing protocols or recommendations for personal use. The Longevity Archive has no vendor relationships and does not recommend where to buy anything.